BRPI0705564B8 - sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos - Google Patents
sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usosInfo
- Publication number
- BRPI0705564B8 BRPI0705564B8 BRPI0705564A BRPI0705564A BRPI0705564B8 BR PI0705564 B8 BRPI0705564 B8 BR PI0705564B8 BR PI0705564 A BRPI0705564 A BR PI0705564A BR PI0705564 A BRPI0705564 A BR PI0705564A BR PI0705564 B8 BRPI0705564 B8 BR PI0705564B8
- Authority
- BR
- Brazil
- Prior art keywords
- soluble substances
- obtaining
- water
- liquid crystal
- poorly water
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004973 liquid crystal related substance Substances 0.000 title 1
- 239000002904 solvent Substances 0.000 title 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000004009 herbicide Substances 0.000 abstract 1
- -1 lipid compound Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000002535 lyotropic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 239000000575 pesticide Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Agronomy & Crop Science (AREA)
- Dispersion Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0705564A BRPI0705564B8 (pt) | 2007-10-10 | 2007-10-10 | sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos |
| PCT/BR2008/000305 WO2009046511A2 (en) | 2007-10-10 | 2008-08-10 | Carrier system for weakly water soluble substances, process for obtaining said system and its uses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0705564A BRPI0705564B8 (pt) | 2007-10-10 | 2007-10-10 | sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0705564A2 BRPI0705564A2 (pt) | 2009-06-16 |
| BRPI0705564B1 BRPI0705564B1 (pt) | 2020-09-15 |
| BRPI0705564B8 true BRPI0705564B8 (pt) | 2021-05-25 |
Family
ID=40549635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0705564A BRPI0705564B8 (pt) | 2007-10-10 | 2007-10-10 | sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BRPI0705564B8 (pt) |
| WO (1) | WO2009046511A2 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114910469B (zh) * | 2021-02-09 | 2025-07-29 | 中国科学院青海盐湖研究所 | 一种测定氯化钾固体样品中十八胺含量的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| EP1233943B1 (en) * | 1999-11-24 | 2011-06-29 | Sugen, Inc. | Ionizable indolinone derivatives and their use as ptk ligands |
| PE20030828A1 (es) * | 2002-03-04 | 2003-11-04 | Novartis Ag | Composicion oftalmica que comprende ascomicina |
| EP1633322A2 (en) * | 2003-06-04 | 2006-03-15 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
-
2007
- 2007-10-10 BR BRPI0705564A patent/BRPI0705564B8/pt active IP Right Grant
-
2008
- 2008-08-10 WO PCT/BR2008/000305 patent/WO2009046511A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0705564A2 (pt) | 2009-06-16 |
| BRPI0705564B1 (pt) | 2020-09-15 |
| WO2009046511A3 (en) | 2010-03-18 |
| WO2009046511A2 (en) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| López-Marqués et al. | Structure and mechanism of ATP-dependent phospholipid transporters | |
| CL2007003187A1 (es) | Compuestos derivados de bencil-benzonitrilo sustituido con glucopiranosilo y sus sales; procedimiento de preparacion; compuestos intermediarios; proceso para preparar los compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de | |
| DOP2010000259A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
| AR061024A1 (es) | Maleato de 5-amino-3- (2'3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d] pirimidin-2-ona. | |
| BRPI0514365A (pt) | aminas policìclicas substituìdas por arila, método para a produção destas, e uso destas como medicamento | |
| UY31277A1 (es) | Nuevos derivados de 6-triazolopiridacina -sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmacéuticas y nueva utilizacion principalmente como inhibidores de met | |
| UY32203A (es) | Amino pirimidinas y su uso en terapia | |
| PA8800701A1 (es) | Sales de maleato de [e]-n-{4-[3-cloro-4-[2-piridinilmetoxi]anilino]-3-ciano-7-etoxi-6-quinolinil}-4-[dimetilamino]-2-butenamide, sus formas cristalinas, procesos para su preparacion, y metodos para su uso | |
| CL2007003389A1 (es) | Formas cristalinas de sales de acido zoledronico; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| PE20141607A1 (es) | Compuestos heterociclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparacion | |
| UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
| Shekunov et al. | Plant alkaloids inhibit membrane fusion mediated by calcium and fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 fusion peptides | |
| ECSP10010664A (es) | Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas | |
| BRPI0915920A2 (pt) | derivados imidazo [1,2-a]pirimidina, o respectivo processo de preparo, a respectiva aplicação a título de medicamentos, composições farmacêuticas e nova utilização notadamente com inibidores de met | |
| CO6351722A2 (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| EA200901389A1 (ru) | Производные фталазина и изохинолина с модулирующим действием на s1p рецепторы | |
| BR112013018616A2 (pt) | adesivo com base em solvente contendo gluconato de clorexidina | |
| UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| Wu et al. | Effect of salt type and alkyl chain length on the binodal curve of an aqueous two-phase system composed of imidazolium ionic liquids | |
| EA201492186A1 (ru) | СОДЕРЖАЩИЕ АНТИТЕЛА К Dll4 СТАБИЛИЗИРОВАННЫЕ КОМПОЗИЦИИ | |
| CL2008000573A1 (es) | Forma cristalina de la sal 3-endo-(8-[2-[ciclohexilmetil-((s)-2,3-dihidroxi-propionil) amino]etil]-8aza-biciclo[3,2,1] oct-3-il)benzamida; proceso para la preparacion de dicha sal; composicion farmaceutica que comprende a dicha sal; y su uso en disfu | |
| UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
| BRPI0705564B8 (pt) | sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos | |
| Krasilnikov et al. | Membrane-targeting antivirals | |
| WO2008040799A3 (en) | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A. ANUIDADE(S). |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2217 DE 02/07/2013. |
|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A. ANUIDADE(S). |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2229 DE 24/09/2013 |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/10/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |